Docosahexaenoic acid (DHA) has been studied for many years owing to its protective effect
on the decline in brain function. DHA intake reduces the risk of Alzheimer's disease (AD) …

Alzheimer's disease (AD) is of major concern in ageing populations and we have used the
Tg2576 mouse model to understand connections between brain lipids and amyloid …

Alzheimer's disease (AD) is a major public health concern in all countries. Although the
precise cause of AD is still unknown, a growing body of evidence supports the notion that …

Background Docosahexaenoic acid,(DHA), the principle omega-3 fatty acid in brain, plays
an important role in neural function. Decreases in plasma DHA are associated with cognitive …

It is believed that the amyloid β-protein (Aβ) plays a causative role in the development of
Alzheimer's disease (AD). The amyloid-β protein precursor (AβPP), a substrate of Aβ, and β …

The primary pathological hallmark of Alzheimer's disease (AD) is neurodegeneration by
neuronal cell death caused by the development of aggregates of beta-amyloid peptide …

Cholesterol and docosahexenoic acid (DHA) may affect degenerative processes in
Alzheimer's Disease (AD) by influencing Aβ metabolism indirectly via the vasculature. We …

Alzheimer's disease (AD) involves progressive deposition of amyloid β-peptide (Aβ),
synapse loss, and neuronal death, which occur in brain regions critical for learning and …

Dietary supplementation with n-3 polyunsaturated fatty acids (n-3 PUFA) reduces amyloid-β
(Aβ) and tau pathology and improves cognitive performance in animal models of Alzheimer's …

Background:: In Alzheimer's disease (AD), the common symptom is loss of memory.
Learning and memory are associated with amoeboid movements of synaptic endings …